News

Obeldesivir provided faster symptom relief but did not reduce hospitalization or all-cause mortality in high-risk nonhospitalized patients with COVID-19.
Messenger RNA, or mRNA – a technology that can instruct cells to fight disease – has fueled breakthroughs from Covid vaccines ...
Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...
The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...
Both public and private funding have plummeted as federal policy changes have thrown the biotech sector into an era of ...
From the Human Genome Project to large-scale initiatives like the UK Biobank and The Cancer Genome Atlas (TCGA), the recent ...
The Trump administration may remove COVID-19 vaccines from the U.S. market as RFK Jr.'s allies gain influence at HHS, with a ...
A new study led by researchers at National Jewish Health has found that recent infection with the common cold - often caused ...
Q: My sister’s 16-year-old son is getting heavy, and I want to say something to her about the health risks so she can help ...